Rohan Kalathiya

Rohan Kalathiya practices at Frederick Health Hospital in Frederick, Maryland, part of Frederick Health.

Rohan Kalathiya's NPI, 1295001659, was assigned on March 29, 2012. Rohan Kalathiya graduated from University of Kentucky College of Medicine in 2012. Rohan Kalathiya holds Maryland license D96905.

Rohan Kalathiya's primary practice is Frederick Health Hospital, at 400 West Seventh St, Frederick, MD 21701 in Frederick County. The practice phone is (240) 566-3300.

Rohan Kalathiya's primary practice is Frederick Health Hospital in Frederick, Maryland, part of Frederick Health. Rohan Kalathiya is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Rohan Kalathiya to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rohan Kalathiya practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Rohan Kalathiya's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Rohan Kalathiya's licenses on file in 2 states: Maryland and Illinois.

CMS data shows 1,569 Medicare services from Rohan Kalathiya across 16 procedure codes in 2024, for 901 Medicare patients. Medicare paid $94,481 for them.

CMS counts 901 Medicare patients who saw Rohan Kalathiya in 2024. The largest group is 65 to 74, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rohan Kalathiya's median patient age at 69, with 41% women.

In 2024, Rohan Kalathiya wrote 190 Medicare Part D claims for 56 patients. 92% of them were for generic drugs. CMS names the drug for 125 of them, across 8 drugs with 11 or more claims each, at $1,461 in total drug cost. In 2023, CMS named 595 claims across 17 drugs.

CMS lists Rohan Kalathiya as offering telehealth. CMS counts 83 procedures of coronary angioplasty and stenting by Rohan Kalathiya, more than 94% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Rohan Kalathiya, published from 2013 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Heart Failure, Cardiac Catheterization and Heart-Assist Devices. Rohan Kalathiya has published most often in J Invasive Cardiol. Rohan Kalathiya's most frequent co-authors are Sandeep Nathan, Jonathan D. Paul and Brian Allan Houston, MD.

Dmand AI links Rohan Kalathiya to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Chronic Limb-Threatening Ischemia and Peripheral Arterial Disease.

CMS Open Payments shows 208 general payments to Rohan Kalathiya from 35 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 66% of the total. Medtronic, Inc. paid the most, $13,169.

Rohan Kalathiya graduated from University of Kentucky College of Medicine in 2012.